2m 2m 2m 2m 2m 2m 2m
CERVOMED (CRVO)
NASDAQ
$3.71-$0.01 (-0.27%)
Price as of Jun 23, 2026 7:59 PM EDT- $38.2MMarket Cap
- -45.37%1-Year Change
- BiotechnologyIndustry
CERVOMED (CRVO)
$3.71-$0.01 (-0.27%)
CRVO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.72 | ||
Change | -$0.41 (-9.93%) | ||
Open | $3.97 | ||
High | $4.11 | ||
Low | $3.70 | ||
Previous Close | $4.13 | ||
Volume | 1,604,010 | ||
30-Day Average Volume | 16,611,151 | ||
1-Week Change | -17.70% | ||
1-Month Change | 21.57% | ||
1-Year Change | -45.37% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 9.3M | ||
Total Assets | $15.1M | ||
Market Cap | $38.2M | ||
Enterprise Value | $30.3M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$8.0M | ||
Free Cash Flow | -$8.0M | ||
EBIT | -$8.0M | ||
EBITDA | -$8.0M | ||
Net Working Capital | $12.8M | ||
EPS | -$0.86 | ||
Enterprise Value/EBITDA | -4 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 4 | ||
P/E | -5 | ||
PEG | -3 | ||
Price/Free Cash Flow | -5 | ||
Price/Operating Cash Flow | -5 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 50 | ||
Last Split Date | 04/19/2022 | ||
Earnings & Revenue